Last Updated: March 23, 2017 Ludlow Research

New Post Public Reply Private Reply Replies (1) Message Board
makebucks
354
Last Updated: March 23, 2017



Ludlow Research Reaffirms $0.02 Target on TXHD Based on Market Potential (NEW YORK) – Ludlow Research reaffirmed its opinion on Textmunication Holdings, Inc. (OTC: TXHD), an online mobile marketing platform service provider, with a valuation target of $0.02 based on rapid growth of SMS operations, Aspire Government IT contracts, and market valuation.

Report Highlights

- Upgrading SMS Capacity to 1 Bill Per Month - Projecting 10x Increase in SMS Volume by Q2 2017 - Retaining Senior Platform Tech Developers - Becoming Emerging Competitor to Twilio - Revenues Growing Quarter over Quarter - Aspire Medicaid IT Contract - Eliminating Toxic Notes/Debt


In the report, Ludlow Research made note of TXHD growing revenues, projected growth of SMS volume on their mobile marketing platform, and Aspire IT Government contract for Medicaid and Medicare programs.

Expanding SMS Capacity

In order to keep up with the demand, the Company announced it was scaling its software platform with the addition of two new Scalability Engineers from one of Silicon Valley's leading technology firms.

On March 10, 2017, the Company announced the addition of Rajeev Varshneya as Technical Advisor, and has more than 20 years with Royal Phillips NV.
Mr. Varshneya roles at Phillips included CEO of Phillips Software Center, VP of Product Strategy, Engineering and Operations and SVP of Technology, Product Development and Strategy. He has also led numerous technology start-ups and is actively involved in government contracting with leading Systems Integrators.
In his role as Technology Advisor, Mr. Varshneya will design a technology roadmap setting Textmunication on a course to be a leading SMS solutions provider. He will bring in his network of technology architects and developers to assist in Textmunication’s technology growth, M&A and market leadership.

The Company is in the final process of delivering a robust and scalable platform capable of sending more than 40 million SMS per day, or capacity of up to 1 billion SMS per month.

For a Company that generates a core of its revenues on a per SMS bases this dramatic upgrade in capacity sets the stage for dramatic growth in revenues for the coming quarters.












Sector Comparison

The Company upgrading of SMS capacity will provide TXHD the necessary software to separate itself from the largest SMS providers, and offer a proprietary solution substantially increasing the value of the company.

What does this mean? This means TXHD could now become one of the emerging competitors to sector leader Twilio, Inc. (NYSE:TWLO), which currently trades at around 5 to 10 times sales.



Recent Earnings

For the three months ended September 30, 2016, the Company reported revenues of $129,943, as compared to $80,289 for the three months ended September 30, 2015. For the nine months ended September 30, 2016, the Company reported revenues of $321,802, as compared to $236,912 for the nine months ended September 30, 2015.

The increase in revenues for the three and nine months ended September 30, 2016 over the prior year periods was due to more customer accounts achieved from a change in their pricing model to become more competitive.

The Company stated they expect to achieve greater revenues for the rest of 2017 as their new SMS capacity could result in a dramatic increase in top line revenue results.



Aspire Government IT Contracts

The Company recently increased its ownership stake to 49% of Aspire Consulting Group LLC, a verified Service Disabled Veteran-Owned Small Business (SDVOSB).

Aspire is headquartered in the business hub of Washington, D.C. and provides IT consulting and solutionbased services to commercial, state, and federal agencies. Aspire is connected to the government procurement community and has advisors who have served in state government cabinet positions and Fortune 500 companies. This network, along with the SDVOSB certification, positions Aspire as a sought after partner for government contracts.

On March 1, 2017, that it was awarded a 10-year government contract as part of a teammate on the CMS SPARC Indefinite Delivery/Indefinite Quantity (IDIQ) contracting vehicle, with a ceiling on the IDIQ at $25 billion, and shared with multiple companies.

The Prime requested Aspire join the team based on its healthcare past performance and powerful SDVOSB certification. Aspire successfully performed on a 2016 Cloud and Big Data healthcare project gaining critical past performance marks.
The remaining teammates come from Fortune 500 companies, and other well-known Federal System Integrators. Strategic teaming is key to winning the numerous task orders delivered under this long-term IDIQ vehicle. The SPARC agreement offers substantial revenue opportunity for Aspire, and once task orders within the IDIQ are won announcements and revenue guidance will be made in public releases.

Task order revenues vary in size, but most are substantial and are multi-year arrangements split amongst the teammates.





There are strict SDVOSB work share mandates required by the U.S. government. The Veterans Benefit Act of 2003 requires each government agency to set aside at least 3% of contracts for SDVOSBs. On the state level, the percentages vary, but in most cases are higher. Aspire is competing for state contracts where the SDVOSB requirement is a minimum 7% of total revenue.
The SPARC agreement also provides Aspire the necessary past performance credentials to compete longterm and be successful with future contracting proposals. Aspire's SDVOSB certification is one of the most coveted in government contracting. The CMS SPARC contract is one of the largest IDIQs in government and carries substantial past performance metrics.

Aspire just submitted a proposal for the Veterans Affairs (VA) VECTOR SDVOSB contract. This is a $25 billion IDIQ centered on Management, Analysis, Training, Outreach, Supply Chain and Human Resource staffing. Aspire's team on VECTOR now awaits the award of this contract. Two other contracts are pending, with one for system modernization of a state's Motor Vehicle Administration (MVA) infrastructure, and other as a subcontractor on a key federal agency.
Aspire has teaming agreements with Northrop Grumman - the #2 federal systems integrator, Tech Mahindra - one of the largest business transformation firms in the world and a Direct hiring agreement with Phase One Consulting Group on its Department of Transportation (DOT) and Commodity Futures Trading Commission (CFTC) programs. The SDVOSB certification helps these companies hit specific government goals as it relates to veteran-owned business credits.

Textmunication acquired a minority-stake in Aspire gaining government contracting access. The partnership also allows Aspire's management team to open new SMS verticals in the government sector.



Share Structure

As of March 2017, the Company had roughly 2.4 billion common shares issued and outstanding. The Company made a strategic move recently by issuing 2 billion shares to the company CEO, which of course under SEC and insider rules is restricted and locked up from being sold into the public market.

Even with the 2.4 billion shares outstanding, upscale in SMS capacity, and pending government IT contracts, a price of $0.02 per share could still be justifiable on their low float inventory, and continued elimination of toxic notes off their balance sheet.

Now, with that said, what could become a real wild card for TXHD could be the potential retirement of those 2 billion shares back into treasury. From our take the 2 billion was issued to maintain control within the company executive hands, while at same time using the increased share structure to wipe out their toxic notes once and for all.

With notes now being retired off the balance sheet, and revenues set to increase in coming quarters, a real wild card could be that those 2 billion shares get retired back into treasury, or into some sort of Series preferred shares, thus decreasing current common shares outstanding back to say 400 million, which of course could have an explosive effect to upside potential to current prices.


Conclusion

Based on TXHD current and projected growth in revenues, increasing SMS capacity to become a major player in text marketing industry, pending Government health IT contracts through their Aspire division, market valuation compared to leader within sector, and possible major reduction in shares outstanding Ludlow Research has reaffirmed its ‘speculative’ valuation target of $0.02 per share based on current share structure, with potential for higher upgrade on any reduction of common shares outstanding in the near future.




About Textmunication Holdings, Inc.

Textmunication Holdings, Inc. is developer in the mobile marketing and loyalty industry, providing cutting-edge mobile marketing solutions, rewards and loyalty to our clients. With a powerful yet intuitive suite of services, clients are able to reach more customers faster and reward them for repeat business through SMS technology. We help clients reach their marketing and revenue goals by educating clients with the most effective tools in mobile marketing, rewards, paperless redemption and loyalty. www.textmunication.com

Follow the Company on Twitter for updates: http://twitter.com/Textmunication


About Ludlow Research
Ludlow Research is a New York based equity research firm that focuses on providing research coverage and investor awareness services to emerging small-cap companies. For over 14 years we have worked to provide our readers with a simple way of evaluating the current and potential value of small-cap companies, while garnering these clients greater market awareness to new investors. For more information on us please visit www.ludlowresearch.com


Disclaimer:

This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Ludlow Capital, Inc ("Ludlow" does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. Ludlow, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Ludlow was compensated three million restricted common shares for ongoing media consulting services, and thus should be considered a possible conflict of interest when reviewing this report and information. Ludlow, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.


Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forwardlooking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.

Forward-Looking Statements This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by law, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.


High Risk
Small and Micro cap, or 'penny stocks', involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 70

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 115

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 0

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 97

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
SpaceMap Tackles Space Traffic With AI Innovation

Updated Category News Views 0

SpaceMap Takes Aim at the Crowded Space Above You ever look up and wonder what's hurtling above our noggins? More satellites than you can shake a stick at, that's what. And don't even start me on the debris floating around. This ain't just rocket science anymore; it's a crowded dance floor, and someone's gotta manage it. Enter SpaceMap, a plucky South Korean startup that...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 56

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading

Top 5 Most Recently Viewed Articles

Disney Postpones Asia Cruise Ship Launch Amid Challenges

Updated Category News Views 232

Disney Delays Launch of Its First Asia Cruise Ship Walt Disney Co. (NYSE: DIS) has announced a three-month delay in the inaugural voyage of its first Asia-based cruise ship, the Disney Adventure. Originally set to embark from Singapore on December 15, the new launch date is now March 10, 2026, due to unexpected setbacks in the shipbuilding process. Challenges in...

Continue Reading
Promising Outcomes from ASPIRO Phase 1/2a Trial for Parkinson's

Updated Category News Views 159

Promising Results from Aspen Neuroscience's Clinical Study Aspen Neuroscience has recently shared encouraging insights from the ASPIRO Phase 1/2a clinical trial, focusing on their innovative cell therapy, ANPD001, aimed at treating Parkinson's Disease. This investigational approach leverages autologous dopaminergic neuronal precursor cells (DANPC) that hold the potential...

Continue Reading
Exploring Honeywell Intl's Options Trends and Market Analysis

Updated Category News Views 213

Understanding Honeywell Intl's Current Options Landscape The dynamic environment of finance recently showcased an intriguing shift with notable bearish movements concerning Honeywell Intl. The latest analysis of options trading data for Honeywell Intl (HON) has spotlighted a total of 10 unique trades that have piqued interest among traders. In an examination of the...

Continue Reading
Transforming Business with Google Agentspace and Premier Cloud

Updated Category News Views 217

Transforming Business with Google Agentspace and Premier Cloud Premier Cloud has been recognized as a launch partner for Google Agentspace, Google's innovative new AI platform that aims to revolutionize enterprise search and productivity. This partnership is a significant milestone for Premier Cloud, a prominent Google Cloud Premier Partner, renowned for its expertise in...

Continue Reading
Transforming Biotechnology: A New Era for Advanced Therapies

Updated Category News Views 156

Innovative Biomanufacturing Comes to Saudi Arabia At the forefront of a new biotechnology initiative, a strategic partnership has emerged between King Faisal Specialist Hospital & Research Centre (KFSHRC) and Germfree Laboratories, LLC, unveiling a state-of-the-art Advanced Therapy Medicinal Product (ATMP) Manufacturing Campus. This exciting development represents a...

Continue Reading